Benzinga | Jan 4, 2022 07:39AM EST

Craig-Hallum Initiates Coverage On iSpecimen with Buy Rating, Announces Price Target of $20

Craig-Hallum analyst Matt Hewitt initiates coverage on iSpecimen (NASDAQ:ISPC) with a Buy rating and announces Price Target of $20.